治疗肥胖症中的糖尿病前期：胰高血糖素样肽-1类似物是答案吗？ - Suppr

Suppr

超能文献

Treating prediabetes in the obese: are GLP-1 analogues the answer?

作者信息

Farr Olivia M, Mantzoros Christos S

机构信息

Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

出版信息

Lancet. 2017 Apr 8;389(10077):1371-1372. doi: 10.1016/S0140-6736(17)30315-X. Epub 2017 Feb 23.

DOI:10.1016/S0140-6736(17)30315-X

PMID:28237265

Abstract

摘要

相似文献

Treating prediabetes in the obese: are GLP-1 analogues the answer?

Lancet. 2017 Apr 8;389(10077):1371-1372. doi: 10.1016/S0140-6736(17)30315-X. Epub 2017 Feb 23.

GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study.

Diabetes. 2015 Jul;64(7):2513-25. doi: 10.2337/db14-1751. Epub 2015 Feb 12.

Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.

Expert Opin Pharmacother. 2014 Dec;15(17):2487-500. doi: 10.1517/14656566.2014.965678. Epub 2014 Sep 26.

Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513-2525.

Diabetes. 2015 Sep;64(9):e28-9; discussion e30-1. doi: 10.2337/db15-0614.

Is there a place for incretin therapies in obesity and prediabetes?

Trends Endocrinol Metab. 2013 Mar;24(3):145-52. doi: 10.1016/j.tem.2013.01.004. Epub 2013 Feb 14.

Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.

J Clin Endocrinol Metab. 2002 Aug;87(8):3768-73. doi: 10.1210/jcem.87.8.8743.

Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.

Metabolism. 2011 Jan;60(1):52-6. doi: 10.1016/j.metabol.2010.01.001. Epub 2010 Feb 11.

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.

Diabetologia. 2002 Aug;45(8):1111-9. doi: 10.1007/s00125-002-0878-6. Epub 2002 Jul 4.

[GLP-1 analogues in treatment of type 1 diabetes mellitus].

Dtsch Med Wochenschr. 2014 Oct;139(42):2123-6. doi: 10.1055/s-0034-1387304. Epub 2014 Oct 7.

Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2330-4. doi: 10.1210/jc.2014-1480. Epub 2014 Jul 16.

引用本文的文献

Prediabetes and Cardiometabolic Risk: The Need for Improved Diagnostic Strategies and Treatment to Prevent Diabetes and Cardiovascular Disease.

Biomedicines. 2024 Feb 4;12(2):363. doi: 10.3390/biomedicines12020363.

Glycemic and metabolic sub-classification of prediabetes and risk factors for cardiovascular disease in the D2d cohort.

Am J Prev Cardiol. 2023 Jul 27;15:100525. doi: 10.1016/j.ajpc.2023.100525. eCollection 2023 Sep.

Family Involvement to Stop the Conversion of Prediabetes to Diabetes.

Korean J Fam Med. 2023 Nov;44(6):303-310. doi: 10.4082/kjfm.23.0019. Epub 2023 Aug 14.

A Systematic Approach to Treating Early Metabolic Disease and Prediabetes.

Diabetes Ther. 2023 Oct;14(10):1595-1607. doi: 10.1007/s13300-023-01455-9. Epub 2023 Aug 5.

The Longitudinal Epidemiologic Assessment of Diabetes Risk (LEADR): Unique 1.4 M patient Electronic Health Record cohort.

Healthc (Amst). 2020 Dec;8(4):100458. doi: 10.1016/j.hjdsi.2020.100458. Epub 2020 Oct 1.

Prevention of Diabetes Mellitus in Patients With Prediabetes.

Am J Cardiol. 2019 Feb 1;123(3):507-512. doi: 10.1016/j.amjcard.2018.10.032. Epub 2018 Nov 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Treating prediabetes in the obese: are GLP-1 analogues the answer?

作者信息

Farr Olivia M, Mantzoros Christos S

机构信息

Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

出版信息

Lancet. 2017 Apr 8;389(10077):1371-1372. doi: 10.1016/S0140-6736(17)30315-X. Epub 2017 Feb 23.

DOI:10.1016/S0140-6736(17)30315-X

PMID:28237265

Abstract

摘要

相似文献

Treating prediabetes in the obese: are GLP-1 analogues the answer?

Lancet. 2017 Apr 8;389(10077):1371-1372. doi: 10.1016/S0140-6736(17)30315-X. Epub 2017 Feb 23.

GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study.

Diabetes. 2015 Jul;64(7):2513-25. doi: 10.2337/db14-1751. Epub 2015 Feb 12.

Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.

Expert Opin Pharmacother. 2014 Dec;15(17):2487-500. doi: 10.1517/14656566.2014.965678. Epub 2014 Sep 26.

Diabetes. 2015 Sep;64(9):e28-9; discussion e30-1. doi: 10.2337/db15-0614.

Is there a place for incretin therapies in obesity and prediabetes?

Trends Endocrinol Metab. 2013 Mar;24(3):145-52. doi: 10.1016/j.tem.2013.01.004. Epub 2013 Feb 14.

Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.

J Clin Endocrinol Metab. 2002 Aug;87(8):3768-73. doi: 10.1210/jcem.87.8.8743.

Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.

Metabolism. 2011 Jan;60(1):52-6. doi: 10.1016/j.metabol.2010.01.001. Epub 2010 Feb 11.

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.

Diabetologia. 2002 Aug;45(8):1111-9. doi: 10.1007/s00125-002-0878-6. Epub 2002 Jul 4.

[GLP-1 analogues in treatment of type 1 diabetes mellitus].

Dtsch Med Wochenschr. 2014 Oct;139(42):2123-6. doi: 10.1055/s-0034-1387304. Epub 2014 Oct 7.

Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2330-4. doi: 10.1210/jc.2014-1480. Epub 2014 Jul 16.

引用本文的文献

Prediabetes and Cardiometabolic Risk: The Need for Improved Diagnostic Strategies and Treatment to Prevent Diabetes and Cardiovascular Disease.

Biomedicines. 2024 Feb 4;12(2):363. doi: 10.3390/biomedicines12020363.

Glycemic and metabolic sub-classification of prediabetes and risk factors for cardiovascular disease in the D2d cohort.

Am J Prev Cardiol. 2023 Jul 27;15:100525. doi: 10.1016/j.ajpc.2023.100525. eCollection 2023 Sep.

Family Involvement to Stop the Conversion of Prediabetes to Diabetes.

Korean J Fam Med. 2023 Nov;44(6):303-310. doi: 10.4082/kjfm.23.0019. Epub 2023 Aug 14.

A Systematic Approach to Treating Early Metabolic Disease and Prediabetes.

Diabetes Ther. 2023 Oct;14(10):1595-1607. doi: 10.1007/s13300-023-01455-9. Epub 2023 Aug 5.

The Longitudinal Epidemiologic Assessment of Diabetes Risk (LEADR): Unique 1.4 M patient Electronic Health Record cohort.

Healthc (Amst). 2020 Dec;8(4):100458. doi: 10.1016/j.hjdsi.2020.100458. Epub 2020 Oct 1.

Prevention of Diabetes Mellitus in Patients With Prediabetes.

Am J Cardiol. 2019 Feb 1;123(3):507-512. doi: 10.1016/j.amjcard.2018.10.032. Epub 2018 Nov 6.